MoonLake Immunotherapeutics earnings per share and revenue

MLTX earnings per share for the last quarter are -0.22 USD whereas the estimation was -0.19 USD which accounts for -13.99% surprise. Företagets omsättning för samma period uppgår till 0.00 USD trots den uppskattade siffran 0.00 USD. Estimated earnings per share for the next quarter are -0.27 USD, and revenue is expected to reach 0.00 USD. Also watch annual changes over time to get a bigger picture of MLTX earnings per share and revenue dynamics.